外围HMGB1与与疾病相关的星球细胞和粉样蛋白相关的O3病理有关
Chandrama Ahmed1, Hendrik J Greve1, Carla Garza-Lombo1
1Department of Pharmacology and Toxicology, Indiana University School of Medicine, The Stark Neurosciences Research Institute, Indianapolis, Indiana, USA.
概括
臭氧暴露会通过改变星体细胞和它们与微质细胞的相互作用,使阿尔茨海默氏病的病理状况恶化. 周围髓状细胞HMGB1对于调节这些臭氧诱导的变化至关重要,提供了潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 环境健康 环境健康
- 免疫学 免疫学 免疫学
背景情况:
- 臭氧 (O3) 是一种空气污染物,与阿尔茨海默病 (AD) 风险增加有关.
- 肺-大脑轴在O3相关的质和粉样蛋白病理中发挥作用.
- 疾病相关天体细胞 (DAA) 在O3诱导的AD病原发生中的特定作用尚不清楚.
研究的目的:
- 调查O3暴露对AD小鼠模型中天体细胞表型和功能的影响.
- 探索外围髓质细胞高流动性组盒1 (HMGB1) 在O3诱导的星球细胞变化中的作用.
- 阐明空气污染对阿尔茨海默症病理生物学贡献的基础机制.
主要方法:
- 空间转录组学和蛋白质组学被用于5xFAD小鼠中O3诱导的天体细胞表型的特征.
- Hmgb1的LysM-Cre的小鼠被用来评估HMGB1在外围髓状细胞中的功能.
- 分析包括天体细胞和斑块计数,蛋白质组和转录组分析,以及天体细胞-微细胞相互作用的评估.
主要成果:
- 在5xFAD小鼠中,O3暴露增加了星细胞和粉样质斑块的数量.
- 暴露于O3阻碍了天体细胞蛋白质反应,增强了DAA转录特征,并增加了天体细胞-微细胞接触.
- 在暴露于O3的小鼠中观察到支气管膜洗免疫细胞HMGB1表达的减少和DAA mRNA标记的失调,特别是那些在髓质细胞中缺乏HMGB1的小鼠.
结论:
- 星球细胞和外围髓状细胞是肺-大脑轴的关键组成部分,在介导O3对AD病理学的影响中发挥作用.
- 周围髓状细胞中的HMGB1是O3诱导的DAA表型的关键调节者.
- 这些发现确定了将空气污染与AD联系起来的新机制,并建议HMGB1作为潜在的治疗点.
相关概念视频
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K


